Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; Dutasteride (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 12 May 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 12 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Jan 2017.